Ernexa Therapeutics (ERNA) Intangibles (2009 - 2026)
Ernexa Therapeutics (ERNA) recorded Intangibles of $6 million in Q1 2022, up 0.2% from $5.99 million a year earlier and up 0.2% from the prior quarter.
Powered by 
Analysis
Ernexa Therapeutics (ERNA) Intangibles (2009 - 2026) Analysis & Trends
At the end of FY2021, Ernexa Therapeutics reported Intangibles of $5.99 million, unchanged from FY2020.
- Annual Intangibles has a five-year compound annual growth rate of 190.4% (FY2016 to FY2021).
- Across earlier years, Intangibles came in at $5.99 million in FY2020 (+760.6%), $696,000 in FY2019 (-88.4%), $6 million in FY2018 (+497.6%) and $1 million in FY2017.
- On a year-over-year basis, Intangibles rose in two of the last five quarters, with growth averaging 152.2%.
- Peak year-over-year performance for Intangibles in the last five years was growth of 760.6% in Q4 2020, against a decline of 92.6% in Q2 2017 at the low end.
- Per Business Quant, the preceding three quarters came in at $5.99 million (Q4 2021), $5.99 million (Q3 2021) and $5.99 million (Q2 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 18.08 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 46.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 56.65 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 24.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 11.80 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 38.15 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 19.54 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 13.42 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 45.96 Bn |
| 10 | Ernexa Therapeutics | 3.31 Mn | -18.41 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 89,000.00 |
| Jun 30, 2025 | 135,000.00 |
| Mar 31, 2025 | 67,000.00 |
| Dec 31, 2024 | 1.03 Mn |
| Jun 30, 2024 | 3.27 Mn |
| Dec 31, 2023 | 1.01 Mn |
| Mar 31, 2022 | 6.00 Mn |
| Dec 31, 2021 | 5.99 Mn |
| Sep 30, 2021 | 5.99 Mn |
| Jun 30, 2021 | 5.99 Mn |
| Mar 31, 2021 | 5.99 Mn |
| Dec 31, 2020 | 5.99 Mn |
| Sep 30, 2020 | 5.99 Mn |
| Jun 30, 2020 | 5.99 Mn |
| Dec 31, 2019 | 696,000.00 |
| Dec 31, 2018 | 6.00 Mn |
| Dec 31, 2017 | 1.00 Mn |
| Jun 30, 2017 | 4,000.00 |
| Mar 31, 2017 | 17,000.00 |
| Dec 31, 2016 | 29,000.00 |
API Access
Ernexa Therapeutics Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=ERNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "ERNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=ERNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();